Consultant’s child born with sickle cell disease despite repeated genotype tests

The story of a consultant in internal medicine whose only child was diagnosed with sickle cell disease has surfaced on social media, prompting discussion about the reliability of genotype testing before marriage. The account, posted by an X user known as @Jah11james, details how the doctor and his wife underwent several genotype screenings that initially indicated the husband was AA and the wife AS, only to receive a final result showing both as AS just days before their wedding.

Repeated testing and the final result

According to the X post, the couple had the habit of testing their blood type multiple times prior to marriage, a common practice in Nigeria where sickle cell disease remains a major public health concern. The first series of tests reportedly identified the husband as genotype AA, meaning no sickle cell trait, and his future wife as AS, indicating she carried one sickle cell gene. The doctor, as quoted by the user, said, “Before he got married, they’d run the test multiple times with his wife, which showed he was AA and she was AS, until a day to their wedding the last test showed they were both AS.”

The last screening, conducted shortly before the wedding, changed the husband’s status to AS as well. The consultant decided to go ahead with the marriage, hoping the new result was erroneous and that the earlier AA finding was correct. He took the risk, believing the earlier results might have been more accurate.

The child’s crisis and the doctor’s reaction

Two years after the wedding, the couple’s only child fell into a sickle cell crisis, a painful episode that can be life‑threatening without prompt care. The same X user wrote that while medical staff were stabilising the child, he saw the father “crying.” When the consultant later explained his distress, he reiterated the sequence of tests that led to the marriage. “I met a consultant in internal medicine, 2 years ago, his only child is a sickle celled, so there was a time she was in crisis and as we were trying to stabilise her I saw the man crying,” the user posted.

The doctor’s quote, as captured by the social media user, show his regret: “He took the risk hoping the last result was wrong and initial ones were correct, unfortunately…” The child’s condition confirmed that both parents carried the sickle cell trait, making it genetically possible for their offspring to inherit sickle cell disease (genotype SS).

Why genotype testing matters in Nigeria

Genotype screening is widely promoted by the Nigerian government and health organisations to reduce the incidence of sickle cell disease, which affects an estimated 2‑3 % of newborns nationwide. Couples are encouraged to undergo testing before marriage, and many states have policies that require the results to be disclosed to prospective spouses. The aim is to inform family planning decisions and avoid the emotional and financial burden of caring for a child with the disease.

Despite these efforts, the story illustrates that testing is not infallible. Laboratory errors, sample contamination, or misreading of results can occur, especially in busy public hospitals where resources are stretched. The consultant’s reliance on multiple tests reflects a common strategy to verify results, yet the final, contradictory outcome suggests a breakdown in quality control.

Public reaction and the way forward

The post quickly attracted comments questioning why a medical professional would proceed with marriage after a test indicated both partners were carriers. Some users expressed sympathy for the family, noting that the doctor “did what many would have done, hoped for the best.” Others called for stricter oversight of diagnostic labs and better counselling for couples faced with conflicting results.

Health experts, while not directly quoted in the source, have long warned that even with accurate testing, carriers cannot be guaranteed to avoid having a child with sickle cell disease, as each pregnancy carries a 25 % chance of producing an SS child when both parents are AS. The tragic outcome in this case show the need for comprehensive genetic counselling, which includes discussion of reproductive options such as prenatal diagnosis or pre‑implantation genetic testing.

What may happen next

The social media account that first shared the story has not disclosed any plans for legal or medical action. The consultant’s personal response to the incident remains private, and there is no indication that the hospital where the tests were performed will be investigated. Nonetheless, the episode adds to a growing catalogue of anecdotal evidence that may push health authorities to review testing protocols and improve public education on the limits of genotype screening.

As the family continues to manage the child’s condition, the broader conversation about sickle cell prevention, testing accuracy, and the emotional toll on healthcare professionals is likely to persist on online platforms and within medical circles.